Skip to Main Content


General Characteristics

Age:83 years
Disease Origin:Sacral
Disease Status:Primary
Source:Silke Bruderlein, Peter Moller
University of Ulm

Molecular Features

Cell morphology:Physaliferous
T expression:Positive; 12.9x that of U-CH2
T localization:Nuclear
CD24 expression:Positive; 10.2x that of U-CH2
HLA Type:
Chromosomal abnormalities:Uncharacterized
Validation results:Validation Report

Growth Conditions

Growth medium:IMDM: RPMI-1640 (4:1) +10% FBS
Freeze medium:70% complete growth medium supplemented with an additional 20% fetal bovine serum and 10% DMSO
Culture conditions:Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Subculturing instructions:Cell Culture Procedures


Characterized By:
  • Cancer Res. 2015 Sep 15;75(18):3823-31. doi: 10.1158/0008-5472.CAN-14-3270. Epub 2015 Jul16. Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting byPharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway. von Witzleben A1